Across TCGA pan-cancer cohorts, LINC01794 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01794’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where LINC01794 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01794 is over-expressed in tumor.
THCA are the cancer types where LINC01794 tumor–normal differential expression is most reproducible.